SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
18 Jan 2023
Historique:
received: 17 11 2022
revised: 09 01 2023
accepted: 14 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Amyotrophic lateral sclerosis (ALS) is a complex disease characterized by the interplay of genetic and environmental factors for which, despite decades of intense research, diagnosis remains rather delayed, and most therapeutic options fail. Therefore, unravelling other potential pathogenetic mechanisms and searching for reliable markers are high priorities. In the present study, we employ the SOMAscan assay, an aptamer-based proteomic technology, to determine the circulating proteomic profile of ALS patients. The expression levels of ~1300 proteins were assessed in plasma, and 42 proteins with statistically significant differential expression between ALS patients and healthy controls were identified. Among these, four were upregulated proteins, Thymus- and activation-regulated chemokine, metalloproteinase inhibitor 3 and nidogen 1 and 2 were selected and validated by enzyme-linked immunosorbent assays in an overlapping cohort of patients. Following statistical analyses, different expression patterns of these proteins were observed in the familial and sporadic ALS patients. The proteins identified in this study might provide insight into ALS pathogenesis and represent potential candidates to develop novel targeted therapies.

Identifiants

pubmed: 36768220
pii: ijms24031899
doi: 10.3390/ijms24031899
pmc: PMC9916400
pii:
doi:

Substances chimiques

Blood Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CRT Foundation
ID : CRT 2017.0891
Organisme : Italian Ministry of Health
ID : 20CEA
Organisme : POR FESR 2014-2020
ID : 1157625

Références

J Neurol Sci. 2014 Nov 15;346(1-2):75-9
pubmed: 25130929
Mol Syst Biol. 2017 Sep 26;13(9):942
pubmed: 28951502
Ann Surg. 2021 Apr 1;273(4):732-742
pubmed: 30946084
Neurodegener Dis. 2016;16(5-6):382-97
pubmed: 27400276
J Neuroimmunol. 2010 Jul 27;224(1-2):80-4
pubmed: 20554025
N Engl J Med. 1992 May 28;326(22):1464-8
pubmed: 1349424
Mol Neurodegener. 2018 Nov 7;13(1):60
pubmed: 30404656
Glia. 2005 Jun;50(4):329-339
pubmed: 15846802
Methods Mol Biol. 2004;239:77-90
pubmed: 14573911
Mol Cell Neurosci. 2006 Mar;31(3):427-37
pubmed: 16337133
CNS Neurol Disord Drug Targets. 2010 Aug;9(4):491-503
pubmed: 20522008
J Cell Physiol. 2019 Dec;234(12):22260-22271
pubmed: 31081124
Eur J Cell Biol. 2004 Dec;83(11-12):613-24
pubmed: 15679106
EBioMedicine. 2020 Sep;59:102844
pubmed: 32651161
Hum Mol Genet. 2010 Aug 15;19(16):3233-53
pubmed: 20530642
Brain Behav Immun. 2013 May;30:186-94
pubmed: 23376170
Anesth Analg. 2023 Jan 1;136(1):163-175
pubmed: 35389379
Alzheimers Res Ther. 2022 Nov 17;14(1):174
pubmed: 36384809
EMBO J. 1991 Nov;10(11):3137-46
pubmed: 1717261
Sci Rep. 2018 Nov 5;8(1):16334
pubmed: 30397248
Amino Acids. 2011 Jan;40(1):145-56
pubmed: 20495836
J Neurol Sci. 2015 Oct 15;357(1-2):22-7
pubmed: 26198021
Trends Immunol. 2002 Jun;23(6):305-13
pubmed: 12072370
Science. 1994 Jun 17;264(5166):1772-5
pubmed: 8209258
Curr Mol Med. 2011 Apr;11(3):246-54
pubmed: 21375489
Mol Cell Biol. 2002 Oct;22(19):6820-30
pubmed: 12215539
J Gerontol A Biol Sci Med Sci. 2015 Jul;70(7):809-16
pubmed: 25123647
Curr Opin Cell Biol. 1998 Oct;10(5):602-8
pubmed: 9818170
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Iran J Neurol. 2016 Apr 3;15(2):85-91
pubmed: 27326363
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195629
MMWR Morb Mortal Wkly Rep. 2017 Dec 22;66(50):1379-1382
pubmed: 29267263
Lab Invest. 2002 Dec;82(12):1617-30
pubmed: 12480912
J Pers Med. 2020 Aug 25;10(3):
pubmed: 32854276
Methods Mol Biol. 2004;281:33-54
pubmed: 15220520
Sci Transl Med. 2017 Apr 5;9(384):
pubmed: 28381538
Aging Cell. 2020 Nov;19(11):e13250
pubmed: 33089916
Eur J Neurol. 2012 Apr;19(4):551-5
pubmed: 21972798
Neurosci Lett. 2001 Jun 8;305(2):119-22
pubmed: 11376898
FASEB J. 2005 Feb;19(2):255-7
pubmed: 15548589
J Cell Sci. 2010 Sep 1;123(Pt 17):2914-21
pubmed: 20682640
Exp Cell Res. 2004 Jul 15;297(2):303-12
pubmed: 15212936
PLoS One. 2010 Dec 07;5(12):e15004
pubmed: 21165148
Ann N Y Acad Sci. 2006 Nov;1085:117-32
pubmed: 17182928
Neurol Clin. 2015 Nov;33(4):807-30
pubmed: 26515623
Neurobiol Dis. 2008 May;30(2):174-85
pubmed: 18316197
Amyotroph Lateral Scler. 2008 Dec;9(6):339-49
pubmed: 18608108
Brain Res. 2008 Oct 27;1237:52-61
pubmed: 18778698
Front Cell Dev Biol. 2019 Nov 21;7:299
pubmed: 31824949
Biochim Biophys Acta. 2016 May;1862(5):1037-46
pubmed: 26327684
Matrix Biol. 2008 Jun;27(5):381-92
pubmed: 18295466
PLoS One. 2013 Nov 05;8(11):e79733
pubmed: 24224000
Matrix Biol. 2014 Jan;33:60-7
pubmed: 23948589
Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H28-42
pubmed: 16951049
J Neurol Sci. 2015;353(1-2):122-9
pubmed: 25958264
J Neurochem. 2011 Sep;118(5):680-94
pubmed: 21722132
Mol Neurobiol. 2007 Oct;36(2):137-51
pubmed: 17952658
Cell Mol Neurobiol. 2016 Mar;36(2):181-94
pubmed: 26993512
J Neuroimmunol. 2014 Nov 15;276(1-2):213-8
pubmed: 25262158
Nature. 2015 Jul 16;523(7560):337-41
pubmed: 26030524
Nat Rev Cancer. 2006 Dec;6(12):961-7
pubmed: 17093504
Degener Neurol Neuromuscul Dis. 2016 May 13;6:49-64
pubmed: 30050368
J Pers Med. 2022 May 19;12(5):
pubmed: 35629249
Eur J Biochem. 1997 Sep 1;248(2):369-73
pubmed: 9346290
J Proteome Res. 2017 Aug 4;16(8):3083-3091
pubmed: 28675934
Bioessays. 1996 Feb;18(2):123-32
pubmed: 8851045
J Biol Chem. 1996 Jan 19;271(3):1544-50
pubmed: 8576151
J Immunol. 2006 Nov 15;177(10):7312-21
pubmed: 17082650
EBioMedicine. 2021 Dec;74:103732
pubmed: 34864363
J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):484-493
pubmed: 35239952
J Allergy Clin Immunol. 2006 Jan;117(1):163-8
pubmed: 16387601
Acta Myol. 2011 Oct;30(2):117-20
pubmed: 22106714
Int J Mol Sci. 2020 Dec 20;21(24):
pubmed: 33419373
Immunity. 2009 Nov 20;31(5):711-21
pubmed: 19836265
J Biol Chem. 1997 Mar 21;272(12):7608-16
pubmed: 9065415
Front Neurol. 2017 Dec 15;8:669
pubmed: 29326641
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
pubmed: 11309499
J Neuroimmunol. 2012 Aug 15;249(1-2):93-5
pubmed: 22633272
Front Neurol. 2017 Oct 13;8:546
pubmed: 29081763
Circulation. 2018 Nov 27;138(22):2482-2485
pubmed: 30524136
Cell. 2006 Jan 13;124(1):207-19
pubmed: 16413492
Sci Rep. 2022 Oct 13;12(1):17147
pubmed: 36229504
J Biol Chem. 2007 Dec 28;282(52):37585-96
pubmed: 17848556
Aging Cell. 2018 Oct;17(5):e12799
pubmed: 29992704
Biomed Res Int. 2014;2014:525097
pubmed: 24991560
Mol Cell Biol. 2005 Aug;25(15):6846-56
pubmed: 16024816
Neurobiol Dis. 2019 Apr;124:263-275
pubmed: 30471417
Lancet Neurol. 2011 Mar;10(3):253-63
pubmed: 21349440
J Biol Chem. 2007 Apr 27;282(17):12928-39
pubmed: 17322299
Mol Cell Biol. 2000 Sep;20(18):7007-12
pubmed: 10958695
PLoS One. 2016 Oct 12;11(10):e0164625
pubmed: 27732645
Exp Cell Res. 2006 Mar 10;312(5):608-22
pubmed: 16442099
Hippocampus. 2010 May;20(5):608-20
pubmed: 19530222
PLoS One. 2016 Oct 13;11(10):e0164689
pubmed: 27737014
J Biol Chem. 2001 Nov 23;276(47):43604-10
pubmed: 11571296
Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):101-17
pubmed: 15000152
Science. 1988 Jun 3;240(4857):1285-93
pubmed: 3287615
PLoS One. 2013 Apr 18;8(4):e61002
pubmed: 23637781
Brief Bioinform. 2011 Sep;12(5):449-62
pubmed: 21873635

Auteurs

Elena Berrone (E)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Giovanna Chiorino (G)

Cancer Genomics Laboratory, Fondazione Edo ed Elvo Tempia, 13900 Biella, Italy.

Francesca Guana (F)

Cancer Genomics Laboratory, Fondazione Edo ed Elvo Tempia, 13900 Biella, Italy.

Valerio Benedetti (V)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Claudia Palmitessa (C)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Marina Gallo (M)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Andrea Calvo (A)

Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.
Neurology, Hospital Department of Neuroscience and Mental Health, Città della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.

Federico Casale (F)

Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.

Umberto Manera (U)

Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.
Neurology, Hospital Department of Neuroscience and Mental Health, Città della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.

Alessandra Favole (A)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Paola Crociara (P)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.
ASL TO4, 10034 Chivasso, Italy.

Camilla Testori (C)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Valerio Carta (V)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Carlotta Tessarolo (C)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Antonio D'Angelo (A)

Department of Veterinary Science, University of Turin, 10095 Grugliasco, Italy.

Giovanni De Marco (G)

Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.
Neurology, Hospital Department of Neuroscience and Mental Health, Città della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.

Maria Caramelli (M)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Adriano Chiò (A)

Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.
Neurology, Hospital Department of Neuroscience and Mental Health, Città della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.

Cristina Casalone (C)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Cristiano Corona (C)

S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH